Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9)
Guntram Schernthaner
Diabetes Metab J. 2021;45(4):615-616.   Published online 2021 Jul 30     DOI: https://doi.org/10.4093/dmj.2021.0081
Citations to this article as recorded by Crossref logo
The management of type 2 diabetes before, during and after Covid-19 infection: what is the evidence?
Leszek Czupryniak, Dror Dicker, Roger Lehmann, Martin Prázný, Guntram Schernthaner
Cardiovascular Diabetology.2021;[Epub]     CrossRef